Perinatal HIV-1 transmission among low income women participants in the HIV/AIDS Control Program in Southern Brazil: A cohort study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 6, 2004, Pages 579-584

  Kreitchmann, Regis ^a,b   Fuchs, Sandra Costa ^b   Suffert, Theodoro ^a   Preussler, Gisele ^a  

^a Secretaria Municipal da Saude   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CELL COUNT; CHILDBIRTH; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PERINATAL PERIOD; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR;

ADULT; ANTI-HIV AGENTS; BRAZIL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INCOME; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RISK FACTORS; RNA, VIRAL; SOCIOECONOMIC FACTORS; VIRAL LOAD;

EID: 2942545721     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00147.x     Document Type: Article

References (22)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331(18):1173-1180.
2. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341(6):385-393.
3. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353(9155):773-780.
4. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States ([revised November 3, 2000]). HIV Clin Trials 2001;2(1):56-91.
5. WHO/UNICEF. New data on the prevention of mother-to-child transmission of HIV and the policy implications: conclusions and recommendations, 2000.
6. Lindegren ML, Byers Jr RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282(6):531-538.
7. Hammers FF, Infuso A, Alix J, et al. Current situation and regional perspective on HIV/AIDS surveillance in Europe. J Acquir Immune Defic Syndr (United States) 2003;32(Suppl 1):39-48.
8. Ministério da Saúde do Brasil. Recomendações para Prevenção da Transmissão Vertical do HIV, 1997-2000.
9. Ministério da Saúde do Brasil. Infecção pelo HIV em criança - Guia de Tratamento Clínico, 1999.
10. Rubini NPM, Arabe J, Cordovil AVDP, et al. HIV-1 vertical transmission in Rio: rate and risk factors. Abstract of the XI International Conference in AIDS, Vancouver, 1996:363.
11. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285(16):2083-2093.
12. Patchen L, Khoshnood K. Risk of perinatal transmission with treatment combinations of intrapartum and newborn zidovudine monotherapy. AIDS Read 2001;11(5):269-277.
13. Dorenbaum A, Cunninghan C, Culnane M, et al. Two dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission - a randomized trial. JAMA 2002;288(2):189-198.
14. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29:484-494.
15. Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1. AIDS 1998;12(5):513-520.
16. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337(21):1485-1490.
17. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999;341(6):394-402.
18. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997;175(1):172-175.
19. Sperling R, Shapiro D, Coombs R, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-1629.
20. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340(13):977-987.
21. European Mode of Delivery Collaboration. Elective cesarean versus vaginal delivery in prevention of HIV-1 transmission: a randomised clinical trial. Lancet 1999;353(9158):1035-1039.
22. Secretaria Municipal da Saúde de Porto Alegre, SINASC - Sistema de Informações sobre Nascidos Vivos, 2000.